Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3795-01
Published September 4, 2013 · Recall initiated: August 12, 2013
Summary
FDA records drug Class II recall D-926-2013, published September 4, 2013 and initiated August 12, 2013. Recalling firm: Hospira, Inc.; Status: Terminated; Reported quantity: 345,800 vials; Lot: Lot 25048DK Exp. 01/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.
What to do
Voluntary: Firm initiated · Letter
Get an email if KETOROLAC TROMETHAMINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- KETOROLAC TROMETHAMINE
- Manufacturer
- Hospira, Inc.
- Distributor
- Naitonwide
- Lot
- Lot 25048DK Exp. 01/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAKetorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular UseOctober 29, 2025
- FDAKetorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc.,October 8, 2025
- FDAKetorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto,July 2, 2025
- FDAKetorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only,August 24, 2022
- FDABenztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufactured in theSeptember 4, 2013
- FDADiazepam Injection, USP, 5 mg/mL, 10 mL, Multiple-dose Sterile Non-pyrogenic, Fliptop Vial, C-IV, Rx Only,September 4, 2013
Questions about this recall
Was Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3795-01 recalled?
Yes. FDA published recall D-926-2013 on September 4, 2013. Reported hazard: Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: KETOROLAC TROMETHAMINE.